Current Advances in Chronic Kidney Disease in Children: Growth, Cardiovascular, and Neurocognitive Risk Factors

Seminars in Nephrology

Volumn 29, Issue 4, 2009, Pages 425-434

  Greenbaum, Larry A ^a   Warady, Bradley A ^b,c   Furth, Susan L ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

cardiovascular diseases; Chronic kidney failure; developmental disabilities; human growth hormone

Indexed keywords

PLACEBO; RECOMBINANT GROWTH HORMONE;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHILDHOOD MORTALITY; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; DEVELOPMENTAL DISORDER; GROWTH DISORDER; GROWTH RETARDATION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INTELLIGENCE QUOTIENT; INTRACRANIAL HYPERTENSION; KIDNEY TRANSPLANTATION; MALNUTRITION; MEMORY DISORDER; METABOLIC ACIDOSIS; NUTRITIONAL DEFICIENCY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SECONDARY HYPERPARATHYROIDISM; SHORT STATURE;

CARDIOVASCULAR DISEASES; CHILD; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; GROWTH; HUMAN GROWTH HORMONE; HUMANS; KIDNEY FAILURE, CHRONIC; RISK FACTORS;

EID: 67650150956     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2009.03.017     Document Type: Article

References (92)

1. Hokken-Koelega A.C., van Zaal M.A., van Bergen W., de Ridder M.A., Stijnen T., Wolff E.D., et al. Final height and its predictive factors after renal transplantation in childhood. Pediatr Res 36 (1994) 323-328
2. Ho M., and Stablein D.M. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) annual report (2003) Rockville, MD
3. Schaefer F., Wingen A.M., Hennicke M., Rigden S., and Mehls O. Growth charts for prepubertal children with chronic renal failure due to congenital renal disorders. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. Pediatr Nephrol 10 (1996) 288-293
4. Schaefer F., Seidel C., Binding A., Gasser T., Largo R.H., Prader A., et al. Pubertal growth in chronic renal failure. Pediatr Res 28 (1990) 5-10
5. Mehls O., Ritz E., Hunziker E.B., Tonshoff B., and Heinrich U. Role of growth hormone in growth failure of uraemia-perspectives for application of recombinant growth hormone. Acta Paediatr Scand Suppl 343 (1988) 118-126
6. Wong C.S., Gipson D.S., Gillen D.L., Emerson S., Koepsell T., Sherrard D.J., et al. Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis 36 (2000) 811-819
7. Furth S.L., Hwang W., Yang C., Neu A.M., Fivush B.A., and Powe N.R. Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 17 (2002) 450-455
8. Furth S.L., Stablein D., Fine R.N., Powe N.R., and Fivush B.A. Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 109 (2002) 909-913
9. Sedman A., Friedman A., Boineau F., Strife C.F., and Fine R. Nutritional management of the child with mild to moderate chronic renal failure. J Pediatr 129 (1996) 13-18
10. Salusky I.B. Bone and mineral metabolism in childhood end-stage renal disease. Pediatr Clin North Am 42 (1995) 1531-1550
11. Goodman W.G. Recent developments in the management of secondary hyperparathyroidism. Kidney Int 59 (2001) 1187-1201
12. Chesney R.W., Moorthy A.V., Eisman J.A., Jax D.K., Mazess R.B., and DeLuca H.F. Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy. N Engl J Med 298 (1978) 238-242
13. Kuizon B.D., Goodman W.G., Juppner H., Boechat I., Nelson P., Gales B., et al. Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53 (1998) 205-211
14. Chantler C., and Holliday M.A. Growth in children with renal disease with particular reference to the effects of calorie malnutrition: a review. Clin Nephrol 1 (1973) 230-242
15. Roelfsema V., and Clark R.G. The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure. J Am Soc Nephrol 12 (2001) 1297-1306
16. Powell D.R., Liu F., Baker B.K., Hinzt R.L., Kale A., Suwanichkul A., et al. Effect of chronic renal failure and growth hormone therapy on the insulin-like growth factors and their binding proteins. Pediatr Nephrol 14 (2000) 579-583
17. Schaefer F., Chen Y., Tsao T., Nouri P., and Rabkin R. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 108 (2001) 467-475
18. Fine R.N., Kohaut E.C., Brown D., and Perlman A.J. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. J Pediatr 124 (1994) 374-382
19. Hokken-Koelega A.C., Stijnen T., de Muinck Keizer-Schrama S.M., Wit J.M., Wolff E.D., de Jong M.C., et al. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338 (1991) 585-590
20. Berard E., Crosnier H., Six-Beneton A., Chevallier T., Cochat P., and Broyer M. Recombinant human growth hormone treatment of children on hemodialysis. French Society of Pediatric Nephrology. Pediatr Nephrol 12 (1998) 304-310
21. Haffner D., Schaefer F., Nissel R., Wuhl E., Tonshoff B., and Mehls O. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 343 (2000) 923-930
22. Broyer M. Results and side-effects of treating children with growth hormone after kidney transplantation-a preliminary report. Pharmacia & Upjohn Study Group. Acta Paediatr Suppl 417 (1996) 76-79
23. Tonshoff B., Haffner D., Mehls O., Dietz M., Ruder H., Blum W.F., et al. Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts. Kidney Int 44 (1993) 199-207
24. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46 (2005) S1-S122
25. Fine R.N., Ho M., Tejani A., and Blethen S. Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 142 (2003) 539-545
26. Seikaly M.G., Salhab N., Warady B.A., and Stablein D. Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS. Pediatr Nephrol 22 (2007) 1195-1204
27. Greenbaum L.A., Hidalgo G., Chand D., Chiang M., Dell K., Kump T., et al. Obstacles to the prescribing of growth hormone in children with chronic kidney disease. Pediatr Nephrol 23 (2008) 1531-1535
28. US Renal Data System. USRDS 2007 annual report: atlas of chronic kidney disease and end-stage renal disease in the United States (2007), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
29. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). 2007 annual report. Rockville, MD (2007)
30. Chavers B.M., Li S., Collins A.J., and Herzog C.A. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62 (2002) 648-653
31. Mitsnefes M.M. Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol 23 (2008) 27-39
32. Grundy S.M. Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy. Am J Cardiol 75 (1995) 45B-52B
33. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
34. Mitsnefes M.M., Ho P.L., McEnery P.T., and Schurman S. Hypertension and progression of chronic renal failure in children: the North American Pediatric Renal Transplant Cooperative Study report. J Am Soc Nephrol 13 (2002) 426A
35. Flynn J.T., Mitsnefes M., Pierce C., Cole S.R., Parekh R.S., Furth S.L., et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension 52 (2008) 631-637
36. Sorof J.M., Cardwell G., Franco K., and Portman R.J. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 39 (2002) 903-908
37. Lande M.B., Carson N.L., Roy J., and Meagher C.C. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Hypertension 48 (2006) 40-44
38. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., and London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99 (1999) 2434-2439
39. Sorof J.M., Alexandrov A.V., Cardwell G., and Portman R.J. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 111 (2003) 61-66
40. Mitsnefes M.M., Kimball T.R., Kartal J., Witt S.A., Glascock B.J., Khoury P.R., et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 149 (2006) 671-675
41. Mitsnefes M.M., Kimball T.R., Border W.L., Witt S.A., Glascock B.J., Khoury P.R., et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 65 (2004) 1461-1466
42. Mitsnefes M.M., Kimball T.R., Border W.L., Witt S.A., Glascock B.J., Khoury P.R., et al. Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis 43 (2004) 721-726
43. Kasiske B.L. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32 (1998) S142-S156
44. National Kidney Foundation. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 41 (2003) S1-S91
45. Fried L.F., Orchard T.J., and Kasiske B.L. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 59 (2001) 260-269
46. Levin A., Djurdjev O., Thompson C., Barrett B., Ethier J., Carlisle E., et al. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis 46 (2005) 799-811
47. Matteucci M.C., Wuhl E., Picca S., Mastrostefano A., Rinelli G., Romano C., et al. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 17 (2006) 218-226
48. El-Husseini A.A., Sheashaa H.A., Hassan N.A., El-Demerdash F.M., Sobh M.A., and Ghoneim M.A. Echocardiographic changes and risk factors for left ventricular hypertrophy in children and adolescents after renal transplantation. Pediatr Transplant 8 (2004) 249-254
49. Morris K.P., Sharp J., Watson S., and Coulthard M.G. Non-cardiac benefits of human recombinant erythropoietin in end-stage renal failure and anaemia. Arch Dis Child 69 (1993) 580-586
50. Stenvinkel P., Carrero J.J., Axelsson J., Lindholm B., Heimburger O., and Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?. Clin J Am Soc Nephrol 3 (2008) 505-521
51. Mitsnefes M.M., Kimball T.R., Kartal J., Witt S.A., Glascock B.J., Khoury P.R., et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J Am Soc Nephrol 16 (2005) 2796-2803
52. Goldstein S.L., Leung J.C., and Silverstein D.M. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin. Clin J Am Soc Nephrol 1 (2006) 979-986
53. Sylvestre L.C., Fonseca K.P., Stinghen A.E., Pereira A.M., Meneses R.P., and Pecoits-Filho R. The malnutrition and inflammation axis in pediatric patients with chronic kidney disease. Pediatr Nephrol 22 (2007) 864-873
54. Balakrishnan V.S., Guo D., Rao M., Jaber B.L., Tighiouart H., Freeman R.L., et al. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65 (2004) 1449-1460
55. Rao M., Wong C., Kanetsky P., Girndt M., Stenvinkel P., Reilly M., et al. Cytokine gene polymorphism and progression of renal and cardiovascular diseases. Kidney Int 72 (2007) 549-556
56. Badiou S., Cristol J.P., Jaussent I., Terrier N., Morena M., Maurice F., et al. Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determination. Clin J Am Soc Nephrol 3 (2008) 423-430
57. Oh J., Wunsch R., Turzer M., Bahner M., Raggi P., Querfeld U., et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106 (2002) 100-105
58. Goodman W.G., Goldin J., Kuizon B.D., Yoon C., Gales B., Sider D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
59. Barker D.J. The developmental origins of insulin resistance. Horm Res 64 (2005) 2-7
60. Luyckx V.A., and Brenner B.M. Low birth weight, nephron number, and kidney disease. Kidney Int 97 (2005) S68-S77
61. Bayrakci U.S., Schaefer F., Duzova A., Yigit S., and Bakkaloglu A. Abnormal circadian blood pressure regulation in children born preterm. J Pediatr 151 (2007) 399-403
62. Hemachandra A.H., Klebanoff M.A., and Furth S.L. Racial disparities in the association between birth weight in the term infant and blood pressure at age 7 years: results from the Collaborative Perinatal Project. J Am Soc Nephrol 17 (2006) 2576-2581
63. Chiu K.C., Chu A., Go V.L., and Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79 (2004) 820-825
64. Shroff R., Egerton M., Bridel M., Shah V., Hiorns M., Donald A., et al. Vitamin D, inflammation and vascular calcification in children on dialysis. Pediatr Nephrol 22 (2007) 1448
65. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., and Cao L.P. 1,25-dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110 (2002) 229-238
66. Levin A., and Li Y.C. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?. Kidney Int 68 (2005) 1973-1981
67. Chesney R.W., Brewer E., Moxey-Mims M., Watkins S., Furth S.L., Harmon W.E., et al. Report of an NIH task force on research priorities in chronic kidney disease in children. Pediatr Nephrol 21 (2006) 14-25
68. Rotundo A., Nevins T.E., Lipton M., Lockman L.A., Mauer S.M., and Michael A.F. Progressive encephalopathy in children with chronic renal insufficiency in infancy. Kidney Int 21 (1982) 486-491
69. McGraw M.E., and Haka-Ikse K. Neurologic-developmental sequelae of chronic renal failure in infancy. J Pediatr 106 (1985) 579-583
70. Polinsky M.S., Kaiser B.A., Stover J.B., Frankenfield M., and Baluarte H.J. Neurologic development of children with severe chronic renal failure from infancy. Pediatr Nephrol 1 (1987) 157-165
71. Bock G.H., Conners C.K., Ruley J., Samango-Sprouse C.A., Conry J.A., Weiss I., et al. Disturbances of brain maturation and neurodevelopment during chronic renal failure in infancy. J Pediatr 114 (1989) 231-238
72. Qvist E., Pihko H., Fagerudd P., et al. Neurodevelopmental outcome in high-risk patients after renal transplantation in early childhood. Pediatr Transplantation 6 (2002) 53-62
73. Valanne L., Qvist E., Jalanko H., Holmberg C., and Pihko H. Neuroradiologic findings in children with renal transplantation under 5 years of age. Pediatr Transplantation 8 (2004) 44-51
74. Warady B.A. Neurodevelopment of infants with end-stage renal disease: is it improving?. Pediatr Transplantation 6 (2002) 5-7
75. Hulstijn-Dirkmaat G.M., Damhuis I.H., Jetten M.L., Koster A.M., and Schroder C.H. The cognitive development of pre-school children treated for chronic renal failure. Pediatr Nephrol 9 (1995) 464-469
76. Honda M., Kamiyama Y., Kawamura K., Kawahara K., Shishido S., Nakai H., et al. Growth, development and nutritional status in Japanese children under 2 years on continuous ambulatory peritoneal dialysis. Pediatr Nephrol 9 (1995) 543-548
77. Warady B.A., Belden B., and Kohaut E. Neurodevelopmental outcome of children initiating peritoneal dialysis in early infancy. Pediatr Nephrol 13 (1999) 759-765
78. Ledermann S.E., Scanes M.E., Fernando O.N., Duffy P.G., Madden S.J., and Trompeter R.S. Long-term outcome of peritoneal dialysis in infants. J Pediatr 136 (2000) 24-29
79. Madden S.J., Ledermann S.E., Guerrero-Blanco M., Bruce M., and Trompeter R.S. Cognitive and psychosocial outcome of infants dialysed in infancy. Child Care Health Dev 29 (2003) 55-61
80. Mendley S.R., and Zelko F.A. Improvement in specific aspects of neurocognitive performance in children after renal transplantation. Kidney Int 56 (1999) 318-323
81. Brouhard B.H., Donaldson L.A., Lawry K.W., McGowan K.R., Drotar D., Davis I., et al. Cognitive functioning in children on dialysis and post-transplantation. Pediatr Transplantation 4 (2000) 261-267
82. Lawry K.W., Brouhard B.H., and Cunningham R.J. Cognitive functioning and school performance in children with renal failure. Pediatr Nephrol 8 (1994) 326-329
83. Gerson A.C., Butler R., Moxey-Mims M., et al. Neurocognitive outcomes in children with chronic kidney disease: current findings and contemporary endeavors. Ment Retard Dev Disabil Res 12 (2006) 208-215
84. Slickers J., Duquette P., Hooper S., and Gipson D. Clinical predictors of neurocognitive deficits in children with chronic kidney disease. Pediatr Nephrol 22 (2007) 565-572
85. Fennell R.S., Fennell E.B., Carter R.L., Mings E.L., Klausner A.B., and Hurst J.R. Association between renal function and cognition in childhood chronic renal failure. Pediatr Nephrol 4 (1990) 16-20
86. Fennell R.S., Fennell E.B., Carter R.L., Mings E.L., Klausner A.B., and Hurst J.R. A longitudinal study of the cognitive function of children with renal failure. Pediatr Nephrol 4 (1990) 11-15
87. Gipson D.S., Hooper S.R., Duquette P.J., Wetherington C.E., Stellwagen K.K., Jenkins T.L., et al. Memory and executive functions in pediatric chronic kidney disease. Child Neuropsychol 12 (2006) 391-405
88. Lande M.B., Kaczorowski J.M., Auinger P., et al. Elevated blood pressure and decreased cognitive function among school-age children and adolescents in the United States. J Pediatr 143 (2003) 720-724
89. Duquette P.J., Hooper S.R., Wetherington C.E., Icard P.F., and Gipson D.S. Brief report: intellectual and academic functioning in pediatric chronic kidney disease. J Pediatr Psychol 32 (2007) 1011-1017
90. Icard P.F., Hower S.J., Kuchenreuther A.R., Hooper S.R., and Gipson D.S. The transition from childhood to adulthood with ESRD: educational and social challenges. Clin Nephrol 68 (2007) 1-7
91. Groothoff J.W., Grootenhius M., Dommerholt A., Gruppen M.P., Offringa M., and Heymans H.S. Impaired cognition and schooling in adults with end stage renal disease since childhood. Arch Dis Child 87 (2002) 380-385
92. Furth S., Cole S., Moxey-Mims M., Kaskel F., Mak R., Schwartz G., et al. Design and Methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1 (2006) 1006-1015